OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
170957

Formosan Union Chemical Corp

Commodity ChemicalsVerified

Formosan Union Chemical Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.18, significantly below the industry median of 0.45, indicating a strong equity position. The company's liquidity is reflected in a current ratio of 2.88, which is above the industry median of 2.1, suggesting robust short-term financial health. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 6.58% and a return on assets (ROA) of 4.85%, both below the industry median of 8.2% and 6.1%, respectively. This suggests that the company is underperforming its peers in terms of capital efficiency and asset utilization. The operating margin of 6.99% is also below the industry median of 9.3%, indicating lower operational efficiency. The company's revenue is distributed across three segments: Alkylation, Resin, and Others. The Alkylation segment contributes the largest share, followed by Resin. Geographically, the company has a strong presence in China, Vietnam, the Philippines, and Guatemala, with a notable portion of revenue derived from these markets. However, the concentration of revenue in these regions may expose the company to geopolitical and economic risks. The company's growth trajectory is modest, with a projected revenue increase of 2.1% for the current fiscal year and 1.8% for the next fiscal year. This growth is driven by stable demand in the chemical products market, particularly in the Alkylation and Resin segments. However, the company's capital expenditure is negative at -66.6 million TWD, indicating a reduction in investment in new projects or capacity expansion. Risk factors include medium liquidity risk due to the negative net cash position and the potential for dilution, although the risk is currently assessed as low. The company has not issued new shares recently, and there are no indications of imminent dilution. However, the company's reliance on international markets exposes it to currency fluctuations and trade policy changes. Recent events include the filing of the 2023 annual report, which provides detailed financial and operational data. The company has also participated in industry conferences to discuss market trends and strategic initiatives. No significant regulatory or legal issues were reported in the latest filings.

30-day price · 1709+0.10 (+0.5%)
Low$17.85High$19.90Close$18.40As of22 May, 00:00 UTC
Profile
CompanyFormosan Union Chemical Corp
Ticker1709.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Formosan Union Chemical Corp is a Taiwan-based company engaged in the manufacture, processing, and trading of chemical products, operating through three segments: Alkylation, Resin, and Others.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Formosan Union Chemical Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.18, significantly below the industry median of 0.45, indicating a strong equity position. The company's liquidity is reflected in a current ratio of 2.88, which is above the industry median of 2.1, suggesting robust short-term financial health. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 6.58% and a return on assets (ROA) of 4.85%, both below the industry median of 8.2% and 6.1%, respectively. This suggests that the company is underperforming its peers in terms of capital efficiency and asset utilization. The operating margin of 6.99% is also below the industry median of 9.3%, indicating lower operational efficiency. The company's revenue is distributed across three segments: Alkylation, Resin, and Others. The Alkylation segment contributes the largest share, followed by Resin. Geographically, the company has a strong presence in China, Vietnam, the Philippines, and Guatemala, with a notable portion of revenue derived from these markets. However, the concentration of revenue in these regions may expose the company to geopolitical and economic risks. The company's growth trajectory is modest, with a projected revenue increase of 2.1% for the current fiscal year and 1.8% for the next fiscal year. This growth is driven by stable demand in the chemical products market, particularly in the Alkylation and Resin segments. However, the company's capital expenditure is negative at -66.6 million TWD, indicating a reduction in investment in new projects or capacity expansion. Risk factors include medium liquidity risk due to the negative net cash position and the potential for dilution, although the risk is currently assessed as low. The company has not issued new shares recently, and there are no indications of imminent dilution. However, the company's reliance on international markets exposes it to currency fluctuations and trade policy changes. Recent events include the filing of the 2023 annual report, which provides detailed financial and operational data. The company has also participated in industry conferences to discuss market trends and strategic initiatives. No significant regulatory or legal issues were reported in the latest filings.
Key takeaways
  • Formosan Union Chemical Corp has a conservative capital structure with a debt-to-equity ratio of 0.18, below the industry median.
  • The company's profitability metrics, including ROE and ROA, are below industry medians, indicating lower capital efficiency.
  • Revenue is concentrated in the Alkylation and Resin segments, with significant exposure to international markets.
  • Growth projections are modest, with a focus on maintaining stable operations rather than aggressive expansion.
  • The company faces medium liquidity risk and potential exposure to geopolitical and economic risks in its international markets.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$9.01B
Gross profit$1.34B
Operating income$631.3M
Net income$588.4M
R&D
SG&A
D&A
SBC
Operating cash flow$563.3M
CapEx-$66.6M
Free cash flow$378.6M
Total assets$12.12B
Total liabilities$3.17B
Total equity$8.95B
Cash & equivalents
Long-term debt$1.65B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$8.95B
Net cash-$1.65B
Current ratio2.9
Debt/Equity0.2
ROA4.9%
ROE6.6%
Cash conversion96.0%
CapEx/Revenue-0.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1709Activity
Op margin7.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin6.5%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin14.9%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity18.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 17:09 UTC#a018f313
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 17:11 UTCJob: 28d668c4